Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Rosacea is a common skin condition mainly causing facial redness.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Two patients got Cushing's syndrome after treatment with Triamcinolone Acetonide for mouth fibrosis, but recovered after stopping the treatment.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

A man with scalp and neck skin issues improved after a year of oral isotretinoin.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

Dermatologists should recognize diverse discoid lupus signs to avoid misdiagnosis.

Adalimumab improved folliculitis decalvans in most patients.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Early diagnosis and strong corticosteroids are crucial for managing lymphocytic cicatricial alopecia.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Long-term glucocorticoid use can cause skin problems like easy bruising and poor wound healing, especially at higher doses.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

cGVHD often severely affects the skin, causing rapid aging and other issues.

A woman developed swelling in her body after taking low-dose oral minoxidil for hair loss, but it resolved after stopping the medication.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.